Man Group plc - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 63 filers reported holding AMRYT PHARMA PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Man Group plc ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q4 2022$9,557,408
+5.5%
1,309,2340.0%0.03%
-19.0%
Q3 2022$9,060,000
-1.2%
1,309,234
-0.2%
0.04%
+7.7%
Q2 2022$9,168,000
-12.9%
1,311,534
+3.0%
0.04%
+5.4%
Q1 2022$10,522,000
-13.8%
1,273,794
+12.7%
0.04%
-5.1%
Q4 2021$12,207,000
+8.6%
1,130,262
+21.6%
0.04%0.0%
Q3 2021$11,240,000929,6660.04%
Other shareholders
AMRYT PHARMA PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,292,00022.96%
Stonepine Capital Management, LLC 6,227,733$43,096,00019.37%
MPM ASSET MANAGEMENT LLC 2,668,843$18,468,0007.03%
Aquilo Capital Management, LLC 1,998,993$13,833,0004.99%
New Leaf Venture Partners, L.L.C. 449,737$3,112,0001.85%
Global Frontier Investments LLC 505,000$3,495,0001.77%
Rubric Capital Management LP 3,600,000$24,912,0001.26%
Telemetry Investments, L.L.C. 123,000$851,0001.09%
Nantahala Capital Management 1,437,458$9,947,0000.64%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$43,828,0000.62%
View complete list of AMRYT PHARMA PLC shareholders